SEC Form SCHEDULE 13G filed by Kyverna Therapeutics Inc.
SCHEDULE 13G - Kyverna Therapeutics, Inc. (0001994702) (Subject)
Live Feed
Delayed 3mPress · Buys · SEC · FDA · Financials
Signed out · 3-min delay · Sign up for real-time
- SEC Form SCHEDULE 13G filed by Bionano Genomics Inc.
SCHEDULE 13G - Bionano Genomics, Inc. (0001411690) (Subject)
- SEC Form SCHEDULE 13G filed by Orion Energy Systems Inc.
SCHEDULE 13G - ORION ENERGY SYSTEMS, INC. (0001409375) (Subject)
- SEC Form SCHEDULE 13G filed by Aspen Aerogels Inc.
SCHEDULE 13G - ASPEN AEROGELS INC (0001145986) (Subject)
- SEC Form CERT filed by Xponential Fitness Inc.
CERT - Xponential Fitness, Inc. (0001802156) (Filer)
- SEC Form 8-K filed by PLAYSTUDIOS Inc.
8-K - PLAYSTUDIOS, Inc. (0001823878) (Filer)
- Jemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer
Approval based on AZUR-1 data showing significant proportion of participants with no detectable signs of cancer one year or more after treatment No disease recurrences reported among responders after median follow up of more than 2 yearsJemperli monotherapy could help eligible patients avoid chemotherapy, radiation and surgeryGSK to present full data from the AZUR-1 interim analysis as a late-breaking abstract at ESMO Congress 2026 in Madrid, Spain on October 25, 2026 SAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, today an
- SEC Form 6-K filed by Rubico Inc.
6-K - Rubico Inc. (0001943421) (Filer)
- Amendment: SEC Form SCHEDULE 13G/A filed by Globant S.A.
SCHEDULE 13G/A - Globant S.A. (0001557860) (Subject)
- SEC Form 424B5 filed by Rubico Inc.
424B5 - Rubico Inc. (0001943421) (Filer)
- CMS Energy's Board of Directors Declares Quarterly Dividend on Common Stock
JACKSON, Mich., Oct. 19, 2026 /PRNewswire/ -- The Board of Directors of CMS Energy has declared a quarterly dividend on the company's common stock. The dividend for the common stock (CUSIP: 125896100) is 57 cents per share. It is payable Dec. 1, 2026, to shareholders of record on Nov. 6, 2026.Additional dividend information, including the tax status of CMS Energy's dividend distributions, can be obtained through the Tax Information section of CMS Energy's website, www.cmsenergy.com.CMS Energy (NYSE:CMS) is a Michigan-based energy company featuring Consumers Energy as its primary business. It also owns and operates independent p
- SEC Form FWP filed by JP Morgan Chase & Co.
FWP - JPMORGAN CHASE & CO (0000019617) (Subject)
- NVIDIA Runs Record Simulation of Fault-Tolerant Quantum Computing at Jülich Supercomputing Centre
News Summary: NVIDIA researchers are using JUPITER — the largest supercomputer in Europe, built at Jülich Supercomputing Centre — for a record-breaking fault-tolerant quantum computing simulation.The 104-qubit simulation is the largest comprehensive simulation of a fault-tolerant quantum computing system to date, with no prior simulations modeling quantum processors in such full detail.The simulation validates a quantum computing approach that uses 90% fewer physical qubits than previous methods, accelerating progress toward useful applications in drug discovery, financial modeling and materials science.JUPITER simulations are providing the quantum industry with actionable insight into the
- SEC Form FWP filed by JP Morgan Chase & Co.
FWP - JPMORGAN CHASE & CO (0000019617) (Subject)
- Penelope Bourbon Commits $250,000 to FCancer as Partnership Marks Fifth Anniversary
The brand also unveils FCancer Batch 5, a limited edition, six-year-old blend of straight whiskeys available nationwide this month Penelope Bourbon is marking five years of its partnership with FCancer with the release of Batch 5, a six-year-old blend of straight whiskeys available at select retailers nationwide starting this October. The annual limited release reflects Penelope’s ongoing commitment to supporting FCancer’s mission of changing the way people think about cancer through prevention, early detection and support. This year, Penelope is pledging $250,000 to the nonprofit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/
- SEC Form DEF 14A filed by Onfolio Holdings Inc.
DEF 14A - Onfolio Holdings, Inc (0001825452) (Filer)
- SEC Form FWP filed by Bank Of Montreal
FWP - BANK OF MONTREAL /CAN/ (0000927971) (Subject)